TABLE 6.
Hypericin pharmacokinetic parameter estimatesa
| Patient no. | Dose (mg/kg) | Tmax | Cmax | AUC (μg/ml × h) | Elimination t1/2 (h)b | V/F (liter)c | CLTB (ml/ min/m2)d |
|---|---|---|---|---|---|---|---|
| 1 | 0.05 | 2.6 | 46.4 | 1.75 | 24.1 | 14.0 | 4.7 |
| 2 | 0.05 | 8.1 | 13.3 | 1.03 | 36.8 | 36.0 | 7.1 |
| 3 | 0.05 | 3.7 | 18.1 | 1.37 | 65.7 | 48.4 | 5.3 |
| 4 | 0.05 | 3.1 | 29.3 | 2.87 | 65.8 | 22.5 | 2.2 |
| 6 | 0.05 | 2.7 | 24.9 | 1.32 | 34.8 | 28.2 | 4.5 |
| 10 | 0.05 | 2.2 | 42.6 | 1.02 | 19.3 | 24.0 | 8.1 |
| 12 | 0.05 | 8.7 | 39.3 | 0.93 | 6.3 | 13.9 | 8.9 |
| Mean | 4.4 | 30.6 | 1.5 | 36.1 | 26.7 | 5.8 | |
| Median | 3.1 | 29.3 | 1.3 | 34.8 | 24.0 | 5.3 | |
| SD | 2.7 | 12.6 | 0.7 | 22.6 | 12.3 | 2.3 | |
| 13 | 0.10 | 5.9 | 42.1 | 1.82 | 22.6 | 109.0 | 22.8 |
| 15 | 0.10 | 6.9 | 69.4 | 4.86 | 37.4 | 71.9 | 9.8 |
| 16 | 0.10 | 3.3 | 30.0 | 2.64 | 58.6 | 112.1 | 11.9 |
| 18 | 0.10 | 1.6 | 118.0 | 2.99 | 16.4 | 44.0 | 10.5 |
| Mean | 4.4 | 64.9 | 3.1 | 33.8 | 84.3 | 13.4 | |
| Median | 4.6 | 55.8 | 2.8 | 30.0 | 90.5 | 11.2 | |
| SD | 2.4 | 39.1 | 1.3 | 18.8 | 32.5 | 6.4 |
Tmax, time to Cmax.
t1/2, half-life.
V/F, volume of distribution/bioavailability.
CLTB, total body clearance.